David Berg

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

David Berg, M.S., was the Director and Cofounder, with Lois Hill Berg, of HEMEX Laboratories before he retired and sold it. He was a medical technologist with a graduate degree in clinical pathology and laboratory medicine, who specialized in the hypercoagulation of blood in infertility, as well as, CFS, fibromyalgia, and Gulf War Illness.

Berg and Joseph Brewer studied coagulation in CFS patients and concluded that approximately 85% of chronic fatigue syndrome patients had hypercoagulation, i.e., the tendency for blood to clot too much, possibly from lower serum levels.[1] He reported that a significant percentage of people obtain remission from anti-coagulation therapy combined with anti-infection therapy.

Talks and interviews[edit | edit source]

Notable studies[edit | edit source]

References[edit | edit source]

  1. Joseph Brewer & David Berg. (2001). Hypercoaguable State Associated with Active Human Herpesvirus-6 (HHV-6) Viremia in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 8, Iss. 3-4, pp. 111-116. http://dx.doi.org/10.1300/J092v08n03_10
  2. http://www.ncf-net.org/library/hemex-hypercoag-1998.htm
  3. https://cfsremission.wordpress.com/treatment/thick-blood-clots-dimension-of-cfs-etc/hemex-protocol-and-dave-berg/
  4. http://www.cfids-me.org/aacfs/poster2.html#berg
  5. Joseph H. Brewer & David Berg. (2001). Hypercoaguable State Associated with Active Human Herpesvirus-6 (HHV-6) Viremia in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 8, Iss. 3-4, pp. 111-116. http://dx.doi.org/10.1300/J092v08n03_10

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.